Cargando…

The making of a potent L-lactate transport inhibitor

L-lactate is an important metabolite, energy source, and signaling molecule in health and disease. In mammals, its transport across biological membranes is mediated by monocarboxylate transporters (MCTs) of the solute carrier 16 (SLC16) family. Malfunction, overexpression or absence of transporters...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bosshart, Patrick D., Kalbermatter, David, Bonetti, Sara, Fotiadis, Dimitrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814091/ https://www.ncbi.nlm.nih.gov/pubmed/36697570 http://dx.doi.org/10.1038/s42004-021-00564-5

Ejemplares similares

Structure and function of a monocarboxylate transporter homolog specific for L-lactate
por: Bosshart, Patrick D., et al.
Publicado: (2019)

Mechanistic basis of L-lactate transport in the SLC16 solute carrier family
por: Bosshart, Patrick D., et al.
Publicado: (2019)

Protein-enriched outer membrane vesicles as a native platform for outer membrane protein studies
por: Thoma, Johannes, et al.
Publicado: (2018)

A procedure and double-chambered device for macromolecular crystal flash-cooling in different cryogenic liquids
por: Jeckelmann, Jean-Marc, et al.
Publicado: (2020)

High-resolution structure of the amino acid transporter AdiC reveals insights into the role of water molecules and networks in oligomerization and substrate binding
por: Ilgü, Hüseyin, et al.
Publicado: (2021)

Cryo-electron microscopic and X-ray crystallographic analysis of the light-driven proton pump proteorhodopsin reveals a pentameric assembly
por: Hirschi, Stephan, et al.
Publicado: (2020)

Peptide transporter structure reveals binding and action mechanism of a potent PEPT1 and PEPT2 inhibitor
por: Stauffer, Mirko, et al.
Publicado: (2022)

The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2
por: Kantipudi, Satish, et al.
Publicado: (2020)

Highly Potent Host-Specific Small-Molecule Inhibitor of Paramyxovirus and Pneumovirus Replication with High Resistance Barrier
por: Shrestha, Neeta, et al.
Publicado: (2021)

Cryo-EM structure and dynamics of the green-light absorbing proteorhodopsin
por: Hirschi, Stephan, et al.
Publicado: (2021)

Structures and dynamics of the novel S1/S2 protease cleavage site loop of the SARS-CoV-2 spike glycoprotein
por: Lemmin, Thomas, et al.
Publicado: (2020)

Pichia pastoris and the Recombinant Human Heterodimeric Amino Acid Transporter 4F2hc-LAT1: From Clone Selection to Pure Protein
por: Kantipudi, Satish, et al.
Publicado: (2021)

Lactate is a potent inhibitor of the capsaicin receptor TRPV1
por: de la Roche, Jeanne, et al.
Publicado: (2016)

Cryo-EM structure of the prefusion state of canine distemper virus fusion protein ectodomain
por: Kalbermatter, David, et al.
Publicado: (2020)

Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and ‐LAT2, and LAT1 and LAT2 Substrates and Inhibitors
por: Kantipudi, Satish, et al.
Publicado: (2021)

Characterization of substrates and inhibitors of the human heterodimeric transporter 4F2hc-LAT1 using purified protein and the scintillation proximity radioligand binding assay
por: Kantipudi, Satish, et al.
Publicado: (2023)

Design and assembly of a chemically switchable and fluorescently traceable light-driven proton pump system for bionanotechnological applications
por: Hirschi, S., et al.
Publicado: (2019)

Structure and supramolecular organization of the canine distemper virus attachment glycoprotein
por: Kalbermatter, David, et al.
Publicado: (2023)

Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation
por: Du, Mengyan, et al.
Publicado: (2022)

Effects of Mutations and Ligands on the Thermostability of the l-Arginine/Agmatine Antiporter AdiC and Deduced Insights into Ligand-Binding of Human l-Type Amino Acid Transporters
por: Ilgü, Hüseyin, et al.
Publicado: (2018)

Inhibitors of Human 5-Lipoxygenase Potently Interfere With Prostaglandin Transport
por: Kahnt, Astrid S., et al.
Publicado: (2022)

Volta Phase Plate Cryo-EM Structure of the Human Heterodimeric Amino Acid Transporter 4F2hc-LAT2
por: Jeckelmann, Jean-Marc, et al.
Publicado: (2019)

Sub-Nanometer Cryo-EM Density Map of the Human Heterodimeric Amino Acid Transporter 4F2hc-LAT2
por: Jeckelmann, Jean-Marc, et al.
Publicado: (2020)

Symmetric molecules with 1,4-triazole moieties as potent inhibitors of tumour-associated lactate dehydrogenase-A
por: Altamimi, Abdul-Malek S., et al.
Publicado: (2017)

The Phosphodiesterase-5 Inhibitor Vardenafil Is a Potent Inhibitor of ABCB1/P-Glycoprotein Transporter
por: Ding, Pei-Rong, et al.
Publicado: (2011)

Role of electrostatic interactions for ligand recognition and specificity of peptide transporters
por: Boggavarapu, Rajendra, et al.
Publicado: (2015)

Discovery and Development of Inhibitors of the Plasmodial FNT-Type Lactate Transporter as Novel Antimalarials
por: Nerlich, Cornelius, et al.
Publicado: (2021)

Exploration of a Large Virtual Chemical Space: Identification of Potent Inhibitors of Lactate Dehydrogenase-A against Pancreatic Cancer
por: Sharma, Horrick, et al.
Publicado: (2023)

Withdrawal-induced delirium associated with a benzodiazepine switch: a case report
por: Bosshart, Herbert
Publicado: (2011)

Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors
por: Kishore Kumar, G.D., et al.
Publicado: (2010)

Combining metformin with lactate transport inhibitors as a treatment modality for cancer - recommendation proposal
por: Benjamin, Don, et al.
Publicado: (2022)

Lactate transport facilitates neurite outgrowth
por: Chen, Kun, et al.
Publicado: (2018)

Targeting cancer lactate metabolism with synergistic combinations of synthetic catalysts and monocarboxylate transporter inhibitors
por: Bridgewater, Hannah E., et al.
Publicado: (2023)

CA-170 – A Potent Small-Molecule PD-L1 Inhibitor or Not?
por: Musielak, Bogdan, et al.
Publicado: (2019)

l-Lactate treatment by photosynthetic cyanobacteria expressing heterogeneous l-lactate dehydrogenase
por: Kato, Yuichi, et al.
Publicado: (2023)

Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment
por: Hanieh, Patrizia Nadia, et al.
Publicado: (2022)

Fluorescence Cross-Correlation Spectroscopy Yields True Affinity and Binding Kinetics of Plasmodium Lactate Transport Inhibitors
por: Jakobowska, Iga, et al.
Publicado: (2021)

Localisation of Lactate Transporters in Rat and Rabbit Placentae
por: Moore, Nigel P., et al.
Publicado: (2016)

The Impact of Preclinical High Potent P2Y(12) Inhibitors on Decision Making at Discharge and Clinical Outcomes in Patients with Acute Coronary Syndrome
por: Hammer, Andreas, et al.
Publicado: (2023)

Potent human uric acid transporter 1 inhibitors: in vitro and in vivo metabolism and pharmacokinetic studies
por: Wempe, Michael F, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_464iab0gt8n6jhtm330j3uns0c